Wells Fargo’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3K | Hold |
9,184
| – | – | ﹤0.01% | 5490 |
|
|
2025
Q1 | $8.91K | Hold |
9,184
| – | – | ﹤0.01% | 5444 |
|
|
2024
Q4 | $10.7K | Hold |
9,184
| – | – | ﹤0.01% | 5423 |
|
|
2024
Q3 | $15.4K | Hold |
9,184
| – | – | ﹤0.01% | 5299 |
|
|
2024
Q2 | $13K | Sell |
9,184
-809
| -8% | -$1.15K | ﹤0.01% | 5317 |
|
|
2024
Q1 | $37.9K | Hold |
9,993
| – | – | ﹤0.01% | 4984 |
|
|
2023
Q4 | $27K | Buy |
9,993
+1,111
| +13% | +$3K | ﹤0.01% | 5093 |
|
|
2023
Q3 | $14K | Hold |
8,882
| – | – | ﹤0.01% | 5350 |
|
|
2023
Q2 | $23.3K | Sell |
8,882
-1,814
| -17% | -$4.77K | ﹤0.01% | 5391 |
|
|
2023
Q1 | $38.9K | Sell |
10,696
-1,050
| -9% | -$3.82K | ﹤0.01% | 5002 |
|
|
2022
Q4 | $46.3K | Sell |
11,746
-6,308
| -35% | -$24.8K | ﹤0.01% | 4593 |
|
|
2022
Q3 | $77K | Buy |
18,054
+5,681
| +46% | +$24.2K | ﹤0.01% | 4447 |
|
|
2022
Q2 | $56K | Sell |
12,373
-3,241
| -21% | -$14.7K | ﹤0.01% | 4701 |
|
|
2022
Q1 | $87K | Buy |
15,614
+3,410
| +28% | +$19K | ﹤0.01% | 5071 |
|
|
2021
Q4 | $76K | Sell |
12,204
-964
| -7% | -$6K | ﹤0.01% | 5342 |
|
|
2021
Q3 | $130K | Sell |
13,168
-6,323
| -32% | -$62.4K | ﹤0.01% | 4986 |
|
|
2021
Q2 | $174K | Buy |
19,491
+1,500
| +8% | +$13.4K | ﹤0.01% | 4787 |
|
|
2021
Q1 | $199K | Buy |
17,991
+17,791
| +8,896% | +$197K | ﹤0.01% | 4830 |
|
|
2020
Q4 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 5946 |
|
|
2016
Q1 | – | Sell |
-8
| Closed | -$1K | – | 5939 |
|
|
2015
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 5772 |
|
|
2015
Q3 | $2K | Hold |
8
| – | – | ﹤0.01% | 5684 |
|
|
2015
Q2 | $2K | Sell |
8
-12
| -60% | -$3K | ﹤0.01% | 5867 |
|
|
2015
Q1 | $5K | Buy |
+20
| New | +$5K | ﹤0.01% | 5576 |
|